Contact information
+44 (0)1865 857240
Tracey Walker
patoruryholman@dtu.ox.ac.uk
https://orcid.org/0000-0002-1256-874X
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, OXFORD. OX3 7LJ
Rury Holman
MB, ChB. FRCP(Lon). FMedSci
Emeritus Professor of Diabetic Medicine
- Emeritus Diabetes Trials Unit Director
- Emeritus NIHR Senior Investigator
- Honorary Consultant Physician
Rury Holman trained in medicine at the University of Bristol and was appointed Honorary Consultant Physician to the University of Oxford NHS Hospitals Trust in 1985, at which time he founded the University of Oxford Diabetes Trials Unit. He was appointed as the first Professor of Diabetic Medicine at the University of Oxford in 1998 and as the founding Academic Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) in 2003. He is a Fellow of the Academy of Medical Sciences, an Emeritus NIHR Senior Investigator and Emeritus Professor of Diabetic Medicine. Professor Holman has won many distinguished international awards including the ADA Harold Rifkin Award for Distinguished International Service, the ADA Outstanding Achievement in Clinical Diabetes Research Award, the Diabetes UK Banting Memorial Lecture, the Diabetes UK Robert Turner Award for Research Impact and the ADA Banting Medal for Scientific Achievement Award.
Recent publications
-
Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242.
Maddaloni E. et al, (2025), Diabetes Care, 48, e61 - e62
-
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Loesch DP. et al, (2025), Nature Communications, 16
-
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.
Dennis JM. et al, (2025), Lancet
-
Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
Maddaloni E. et al, (2025), Diabetes Care, 48, 235 - 242
-
The Science of Diabetes and a Life of Trials: The 2024 Banting Medal for Scientific Achievement Award Lecture.
Holman RR., (2025), Diabetes, 74, 164 - 174